These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33893475)

  • 1. Prospective Metamemory Monitoring of Episodic Visual Memory in Community-Dwelling Older Adults with Subjective Cognitive Decline and Mild Cognitive Impairment.
    Chi SY; Chua EF; Kieschnick DW; Rabin LA
    Arch Clin Neuropsychol; 2021 Nov; 36(8):1404–1425. PubMed ID: 33893475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective metamemory monitoring of semantic memory in community-dwelling older adults with subjective cognitive decline and mild cognitive impairment.
    Chi SY; Chua EF; Kieschnick DW; Rabin LA
    Neuropsychol Rehabil; 2022 Apr; 32(3):429-463. PubMed ID: 33106082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness of memory deficits in subjective cognitive decline, mild cognitive impairment, Alzheimer's disease and Parkinson's disease.
    Lehrner J; Kogler S; Lamm C; Moser D; Klug S; Pusswald G; Dal-Bianco P; Pirker W; Auff E
    Int Psychogeriatr; 2015 Mar; 27(3):357-66. PubMed ID: 25382659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective memory on a novel clinical task in older adults with mild cognitive impairment and subjective cognitive decline.
    Rabin LA; Chi SY; Wang C; Fogel J; Kann SJ; Aronov A
    Neuropsychol Rehabil; 2014; 24(6):868-93. PubMed ID: 24875614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential focal and nonfocal prospective memory accuracy in a demographically diverse group of nondemented community-dwelling older adults.
    Chi SY; Rabin LA; Aronov A; Fogel J; Kapoor A; Wang C
    J Int Neuropsychol Soc; 2014 Nov; 20(10):1015-27. PubMed ID: 25401793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into memory and functional abilities in individuals with amnestic mild cognitive impairment.
    Chudoba LA; Schmitter-Edgecombe M
    J Clin Exp Neuropsychol; 2020 Oct; 42(8):822-833. PubMed ID: 32957853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of independence in instrumental activities of daily living: Amnestic versus nonamnestic MCI.
    Putcha D; Tremont G
    J Clin Exp Neuropsychol; 2016 Nov; 38(9):991-1004. PubMed ID: 27240585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of Subjective Executive Functioning in Older Adults with aMCI and Subjective Cognitive Decline.
    Carmasin JS; Roth RM; Rabin LA; Englert JJ; Flashman LA; Saykin AJ
    Arch Clin Neuropsychol; 2021 Aug; 36(6):1012-1018. PubMed ID: 33454755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences regarding the five-factor personality model in patients with subjective cognitive decline and mild cognitive impairment.
    Berger-Sieczkowski E; Gruber B; Stögmann E; Lehrner J
    Neuropsychiatr; 2019 Mar; 33(1):35-45. PubMed ID: 30328583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anosognosia in Mild Cognitive Impairment: Lack of Awareness of Memory Difficulties Characterizes Prodromal Alzheimer's Disease.
    Bastin C; Giacomelli F; Miévis F; Lemaire C; Guillaume B; Salmon E
    Front Psychiatry; 2021; 12():631518. PubMed ID: 33868048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta.
    Li Q; Pan FF; Huang Q; Lo CZ; Xie F; Guo Q
    Front Aging Neurosci; 2022; 14():1046445. PubMed ID: 36389070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory awareness disruptions in amnestic mild cognitive impairment: comparison of multiple awareness types for verbal and visuospatial material.
    Ryals AJ; O'Neil JT; Mesulam MM; Weintraub S; Voss JL
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2019 Jul; 26(4):577-598. PubMed ID: 30080435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging.
    Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
    Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Cerebrovascular Reactivity in Mild Cognitive Impairment Phenotypes.
    Glass Umfleet L; Pommy J; Cohen AD; Allen M; Obarski S; Mason L; Berres H; Franczak M; Wang Y
    J Alzheimers Dis; 2023; 94(4):1503-1513. PubMed ID: 37424462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Link between Handgrip Strength and Executive Functioning: A Cross-Sectional Study in Older Adults with Mild Cognitive Impairment and Healthy Controls.
    Herold F; Labott BK; Grässler B; Halfpaap N; Langhans C; Müller P; Ammar A; Dordevic M; Hökelmann A; Müller NG
    Healthcare (Basel); 2022 Jan; 10(2):. PubMed ID: 35206845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Error monitoring in amnestic mild cognitive impairment: Cognitive correlates and relationship to measures of everyday function.
    Pagán CR; Arrotta K; Chilton RC; Schmitter-Edgecombe M
    Neuropsychology; 2023 Nov; 37(8):933-942. PubMed ID: 36689394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Subjective Cognitive Complaints Between Non-Demented Older Adults from a Memory Clinic and the Community.
    Markova H; Nikolai T; Mazancova AF; Cechova K; Sheardova K; Georgi H; Kopecek M; Laczó J; Hort J; Vyhnalek M
    J Alzheimers Dis; 2019; 70(1):61-73. PubMed ID: 31177209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
    Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
    Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.